Media Bias Against SNFs Again
The New York Times is at it again, and the reporters don’t want to do some simple math. Well, well, it looks like The New York Times is at it again. Two weeks ago it had a sensationalist story about residents “held” in nursing facilities. Last weekend, they continued on the theme of the disabled being confined in nursing facilities and ready to go home. The gist of the story was that home and community based care is what the elderly and disabled want (true), and that it is cheaper to boot (not so true). In fact, they cited Washington State as claiming that they can care for seven people at home for the cost of one person in a nursing facility. Really? The Washington Medicaid daily... Read More »
Age before location
Highlighting a growing issue for the country’s aging skilled nursing facility inventory, a facility’s regional advantage may not matter much for owners of facilities in high barrier-to-entry markets looking to maximize value. Surprisingly, the Northeast region, because of its higher average income, property values and barriers to entry, saw the highest average cap rate of any region in 2015, at 13.3%. This is up 70 basis points from the average in 2014 of 12.6%, and up 90 basis points from 2013, when the region averaged the lowest cap rate in the country. Conversely, the North Central region, which has seen tremendous growth in skilled nursing development (buoyed by Mainstreet’s pipeline),... Read More »
Changes at HCP, Brookdale, Genesis
Earnings season brings more than just earnings to the surface for some companies. What can I say? It has been quite a week, and we are only at Wednesday. On Monday subscribers received my initial take on HCP’s announcement about spinning out its HCR ManorCare portfolio into a new REIT. Maybe management thought it was necessary, but I really think we are going to be hearing some negative news in the future, and if so, it will make HCP’s decision look better. Just look at the performance of Genesis Health in the first quarter, which sent its share price plummeting by 20% yesterday. One problem is that with the HCR portfolio representing more than 25% of HCP’s revenues, with it gone,... Read More »
